| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Terumo Medical Corporation (TMC), a leading medical device manufacturer employs approximately 700 people in offices throughout the United States, with its corporate headquarters located in Somerset, NJ.
Sunlit Gardens Assisted Living is a Alta Loma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device
Pacific Pulmonary Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Novato, CA. To find more information about Pacific Pulmonary Services, please visit www.ppsc.com